Indian Journal of Respiratory Care

IJRC Email      Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  13 (2024)
Volume  12 (2023)
Volume  11 (2022)
Volume  10 (2021)
Volume  9 (2020)
Volume  8 (2019)
Volume  7 (2018)
Volume  6 (2017)
Volume  5 (2016)
Volume  4 (2015)
Volume  3 (2014)
Volume  2 (2013)
Volume  1 (2012)
Related articles

VOLUME 7 , ISSUE 1 ( January-June, 2018 ) > List of Articles

CASE REPORT

Therapeutic Implications of Monitoring End-tidal Carbon Dioxide in SubMassive Pulmonary Embolism

Sunil Kumar Garg, Pragya Garg

Keywords : Alveolar dead space, end.tidal carbon dioxide, submassive pulmonary embolism, thrombolytics

Citation Information : Garg SK, Garg P. Therapeutic Implications of Monitoring End-tidal Carbon Dioxide in SubMassive Pulmonary Embolism. Indian J Respir Care 2018; 7 (1):53-55.

DOI: 10.4103/ijrc.ijrc_18_17

License: CC BY-NC-SA 3.0

Published Online: 02-12-2022

Copyright Statement:  Copyright © 2018; Indian Journal of Respiratory Care.


Abstract

While managing submassive pulmonary embolism in Intensive Care Unit, it is always a challenge to identify the parameters to identify the deterioration. It is important to understand it as further therapeutic decision about the use of thrombolytics is based on its recognition. Bedside monitoring of end.tidal carbon dioxide which is readily available, continuous, noninvasive, and nonoperator dependent can be of help in deciding on the need of thrombolytics in such cases before development of hypotension.

HTML PDF Share
  1. Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: A scientific statement from the American Heart Association. Circulation 2011;123:1788-830.
  2. Treatment of Sub Massive Pulmonary Embolism: Full Dose, Half Dose or no Dose? Available from: http://www.rebelem.com/treatment-of-submassive-pe-full-dose-half-dose-or-no-dose/. [Last accessed 2017 Aug 15].
  3. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e419S-96S.
  4. Martin C, Sobolewski K, Bridgeman P, Boutsikaris D. Systemic thrombolysis for pulmonary embolism: A Review. P T 2016;41:770-5.
  5. Schmidt GA. Pulmonic embolic disorders: Thrombus, air and fat. Principles of Critical Care. New York: McGraw-Hill; 1992. p. 1476-92.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.